SEARCH

SEARCH BY CITATION

A

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

abdominal, 2163

abdominal fat, 199, 336

abdominal fatness, 1992

abdominal obesity, 60

aboriginal Canadians, 500

aborigine, 183

absenteeism, 920

academic, 88

academic performance, 1839

accelerometers, 2259

acetyl-coenzyme A carboxylase, 25S, 2145

Acipimox, 143S

ActiGraph, 2000

activity limitation, 2042

acute insulin response to glucose, 67

Acyl-CoA synthetase, 1201

Acyl-CoA synthetase long chain, 1201

adenosine monophosphate-activated protein kinase, 201S

adenosine monophosphate kinase, 2145

adherence, 1383, 2007

adipocyte, 9S, 28, 128S, 398, 974, 994, 1303, 1515, 2136

adipocyte differentiation, 1890

adipocytokine, 1132, 1571

adipogenesis, 1543, 1691, 1890

adipokine, 228, 242S

adiponectin, 9S, 60, 128S, 242S, 319, 423, 500, 826, 1320, 1498, 1505, 1511, 2145, 2224

adiponectin gene, 368

adiponectin receptors, 28

adipose, 1118

adipose tissue, 52, 128S, 309, 826, 1515, 1905

adipose tissue physiology, 1890

adiposity, 156, 215, 480, 1010, 1312, 1579, 1839, 1921

adolescents, 377, 448, 855, 1231, 1771, 1825, 2236, 2266

adrenal corticotropic hormone, 235

adult, 1462, 1724, 2259

adult obesity, 1846

African American, 97, 122, 415, 526, 980, 1231, 1412

aging, 902, 1142, 1921, 2277

agouti-related peptide, 254S

agreement, 774, 1731

ajoene, 388

algorithm, 1961

ambulatory blood pressure monitoring, 1708

amlodipine, 1586

amygdala, 1028

amylin, 250S

androgen, 1662

androgen receptor, 662

anemia, 1724

angiotension-converting enzyme inhibitor, 1586

anthropometric indices, 1019

anthropometry, 244, 415, 727, 1181, 1854, 1949

antioxidant, 2224

antral motility, 1363

apoptosis, 388, 1691

apoptosis-inducing factor, 388

arcuate nucleus, 254S

armband, 2217

aromatization, 662

arrhythmia, 1378

arteriole, 206

Asians, 656

assessment, 51S, 53S

association, 529, 650

association study, 14

atherosclerosis, 25S, 799, 1571

atrial repolarization, 1378

attributable fraction, 2071

atypical antipsychotics, 36

autonomic pathways, 1003

B

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

bariatric surgery, 51S, 53S, 70S, 83S, 90S, 645, 1511, 1553, 1961

basal metabolic rate, 690

beef, 1211

beef board, 967

behavior, 97

behavioral therapy, 464, 2007

beverages, 1966

bias, 1802, 2054

biliopancreatic diversion, 1511

binge eating, 1244

bioelectrical impedance analysis, 415, 1731, 2064

biomechanics, 1789, 1949

biopsy specimens, 357

birth length, 1257

birth weight, 1257, 2193

bivariate, 1192

blood–brain barrier, 234S

blood lipids, 2154

blood volume, 1172

Blue Mountains Eye Study, 206

BMI, 51S, 139, 156, 183, 188, 206, 289, 301, 327, 480, 509, 526, 727, 870, 884, 909, 1192, 1462, 1637, 1708, 1802, 1874, 1931, 1975, 2042, 2080, 2107, 2132, 2184, 2294

body composition, 20S, 228, 258, 727, 819, 1320, 1438, 1731, 1914, 2064, 2089, 2242

body contouring, 1626

body fat, 855, 2064

body fat mass, 1854

body fat percentage, 1854

body height, 301

body image, 1626, 2132

body weight, 301, 1562, 2154

body weight changes, 902, 1444

bone mass, 819

bone mineral density, 1320

bone turnover, 1940

brain and behavior, 345

breast cancer, 1854

breast-feeding, 491, 1371

brown adipose tissue, 405, 216S

bupropion, 1863

butyrate, 683

C

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

C75, 201S

cafeteria diet, 1118

calcium, 2242

calcium absorption, 1940

caloric deficit, 1211

caloric restriction, 115, 974

calorimetry, 673

candidate genes, 529

carbohydrates, 855

cardiac adiposity, 1679

cardiac function, 273

cardiac ionic currents, 778

cardiac steatosis, 1586

cardiorespiratory fitness, 1579

cardiovascular disease, 280, 759, 1046, 1172, 1264, 1330, 2277, 2294

cardiovascular fitness, 870

cardiovascular risk, 128S

cardiovascular risk factors, 377, 1868

cardiovascular stress, 273

carnitine palmitoyltransferase-1, 201S

carotid artery intima media thickness, 1708

catch-up growth, 1330

C57BL/6J mouse, 1294

CC chemokine, 799

cDNA microarray, 1294

cell biology, 2136

cell culture, 1898

cell signaling, 2136

cereal, 1392

cervical cancer screening, 526

cesarean section, 770

chemokines, 1353

childhood, 431, 1498, 2173

childhood obesity, 131, 1596, 1846

childhood overweight, 491, 1647

children, 765, 847, 989, 1010, 1073, 1392, 1755, 1771, 1789, 1966, 2236, 2249, 2284

Chinese, 2089

cholecalciferol supplementation, 1739

cholecystokinin, 250S

cholesterol, 1868

cholesterol efflux, 1874

cholesterol synthesis, 1155

cholesteryl ester transfer protein, 812

chronic inflammation, 799, 1886

chronic stress, 327

cognitive, 863

cohort effect, 902

cohort study, 1462

cold, 1914

college students, 1438

combined corticotropin-releasing hormone plus arginine-vasopressin test, 235

commodity promotion, 967

companion animals, 1762

comparative study, 2217

compliance, 1383

computed tomography, 336, 1181

computed tomography attenuation, 73

construct validity, 1429

continuing care, 464, 1244

controls, 2259

coping, 1802

coronary heart disease, 121S, 2099

correction factor, 252

corticosterone, 1905

cortisol, 235, 1056

cost-effectiveness, 1093

cost of illness, 920

counseling, 1485

count cut-points, 2000

C-reactive protein, 14, 121S, 2200

Cre/loxP, 222S

crime, 518

cross-sectional study, 1832

cut-off values, 1992

cyclic adenosine monophosphate, 398

cytokines, 1868

D

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

dairy board, 967

dairy products, 1010

decerebrate, 216S

Delta Trac II, 1755

depression, 90S, 373

depressive symptoms, 122

dexamethasone, 19

diabetes, 25S, 121S, 894, 1085, 1164, 1250, 1880, 1201

diagnosis, 1485

diagnostic criterion, 696

diet, 710, 737, 989, 1283, 1378, 1444, 1777, 1966

dietary calcium, 1739

dietary fiber, 423

dietary guidelines, 1383

dietary patterns, 2034

dietary recall, 1073

diet-induced obesity, 192S, 778

dieting, 115, 2236

dieting history, 70S

diet quality index, 1383

disability, 1219, 1637

discrimination, 1421

disease management, 645

disinhibition, 131

disordered eating, 139, 1244

docosahexaenoic acid, 1931

dopamine type 2 receptor, 36

doubly labeled water, 156

DXA, 244, 258, 415, 727, 819, 1274, 1731, 2089

E

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

eating behavior, 343, 431

eating disorder characteristics, 148

eating disorders, 77S

eating in the absence of hunger, 131

economic evaluation, 1093

education, 327, 909, 1085, 1421, 2080

effort test, 273

elderly, 244, 1485

electrocardiography, 1378

electron beam tomography, 244

employment, 920, 1637

endocannabinoid, 259S

endothelin-1, 398

energy balance, 345, 1914

energy density, 1795

energy expenditure, 216S, 273, 1739, 2154

energy homeostasis, 1562

energy intake, 838, 1073, 1283

energy metabolism, 690

energy restriction, 838

environment, 518, 847

environmental factors, 2210

enzyme-linked immunosorbent assay, 199

Eotaxin, 799

Eotaxin-2, 799

epicardial adipose tissue, 1679

epicardial fat, 1679

epidemiology, 106, 1113, 1454, 1832, 2054, 2294

erythrocytes, 1505

esculetin, 1691

estradiol, 1954

estrogen, 662, 1662, 1940

ethnic differences, 1019

ethnic groups, 301

ethnicity, 156, 415, 717, 819, 2249

Europeans, 759

evening hyperphagia, 77S

evidence-based medicine, 1485

excess mortality, 2071

excess weight, 717

exercise, 97, 357, 701, 1219, 1662, 1771, 1777, 1975, 1992, 2224

exercise intensity, 2018

exercise recommendations, 2259

exercise training, 1294

expectation, 863

expert systems, 266

explicit attitudes, 440

extracellular signal-regulated kinases 1 and 2, 1303

extramyocellular lipid, 73, 1700

extreme obesity, 63S, 70S, 77S, 83S, 90S

F

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

families, 1392

family dinner, 2266

fast food, 2034

fasting, 194

fasting glucose, 1708

fat, 431

fat and lean ratios, 1685

fat cell size, 1543

fat free mass, 273, 1854

fat mass, 1605, 2184, 2242, 2284

fat metabolism, 1700

fat oxidation, 1064

fatty acid oxidation, 1201

fatty acids, 34S, 215

fatty acid synthase, 201S

fatty acyl coenzyme A, 25S

feeding, 259S, 1535

feeding behavior, 431, 2026

feeding practices, 343

female, 2236

femoral, 2163

fetal programming, 1330, 1880

fiber, 1523

flatfoot, 1949

Fluid Milk Board, 967

focus, 863

follicle count, 1954

follitropin receptor knockout, 1142

food cravings, 115

food intake, 222S, 254S, 1056, 1363, 2154

food motivation, 1028

food patterns, 1444

food preferences, 343

foot, 1949

formula diets, 135S

FOX04, 188

FOX01a, 188

FOX03a, 188

free fatty acid, 20S, 1124

free testosterone index, 235

function, 509

functional magnetic resonance imaging, 1028

G

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

gastric bypass, 194, 472, 1626, 1940

gastric pacemakers, 143S

gastric tone and accommodation, 1363

gastroesophageal reflux disease, 696

gender, 2249

gender differences, 131

gene, 683, 1863

gene expression, 52, 1118, 1543

generic advertising, 967

gene therapy, 1003, 1312

genetic association study, 1880

genetic epidemiology, 1874

genetic factors, 826

genetic polymorphism, 1880

genetics, 131, 650, 753, 1028, 1454, 2119

genetic subtypes, 1685

genome scan, 1192, 1596

geriatric, 509

gestational age, 1257

ghrelin, 194, 228S, 250S, 383, 1003, 1056, 1553

ghrelin-A, 19

GHS-R1a, 19

glucagon, 250S

glucagon-like peptide 1, 250S, 683, 1523

glucocorticoid receptor, 759

glucocorticoids, 794, 1515, 1647

glucose, 9S, 295

glucose clamp technique, 1250

glucose intolerance, 1142

glucose metabolism, 67

glucose tolerance, 2200

glucose transport, 34S

glutamate decarboxylase 2 gene, 650

glycemic index, 2200

glycerol, 1124

glycogen, 34S

gonadotropins, 1954

group support, 464

growth, 2136, 2173

growth acceleration, 2173

growth hormone, 383, 1056

growth hormone-releasing peptide-2, 1056

H

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

haplotype, 1498

health behavior change, 266

health care delivery, 1402

health care utilization, 1472

health insurance, 645

health-related quality of life, 448, 1429

health risk indicators, 727

health status, 2042

health surveys, 920

heartburn, 696

height, 289, 1274

heparin, 1961

heritability, 1192

hexose-6-phosphate dehydrogenase, 794

high-density lipoprotein cholesterol, 812, 1874

high-fat diet, 1294, 1344

high-sucrose diet, 1320

hispanics, 526

histamine H3 receptor antagonist, 2154

H magnetic resonance spectroscopy normalization, 73

HMO, 1107

homebound, 509

homeostasis, 259S

homeostasis model assessment of insulin resistance, 1515

homocysteine, 1921

hormone profile, 383

hormone replacement therapy, 1046

human, 28, 794

human immunodeficiency virus, 994

human obesity gene map, 529

human primary preadipocytes, 1890

hunger, 838

hypercaloric diet, 1330

hyperlipidemia, 2177

hypertension, 894, 1505

hypothalamus, 208S, 222S, 242S, 1003, 1312, 1905

I

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

immigrants, 1113

Impact of Weight on Quality of Life, 472

Impact of Weight on Quality of Life-Kids, 448

implicit attitudes, 440

incidence, 206

income, 909

indirect calorimetry, 690, 2000, 2217

individual variation, 1914

infancy-childhood-puberty growth model, 2173

infants, 491, 1107, 1371, 2173

infectobesity, 1905

inflammation, 9S, 309, 500, 1118, 1142, 1353, 1747, 2119, 2127, 2224

inhibin B, 1954

insulin, 19, 192S, 234S, 295, 398, 753, 1003, 1553, 1716, 1931

insulin receptor, 1142

insulin resistance, 20S, 25S, 34S, 67, 309, 787, 826, 994, 1019, 1064, 1118, 1155, 1164, 1250, 1344, 1454, 1543, 1747, 1886, 2145

insulin secretion, 67, 1579, 2200

insulin sensitivity, 60, 1046, 1250, 1498, 1579, 2200

intentional weight loss, 1219

intention-to-treat, 1777

interaction, 1874

interleukin-6, 14, 1454, 1868

interleukin-6 g.–174G>C promoter polymorphism, 14

internet, 266

internet-based weight loss, 1231

interstitial glycerol, 2163

intervention, 1616, 2210, 2242

intra-abdominal obesity, 1155

intramuscular fat, 1064

intramyocellular lipid, 73, 228, 1700

intramyocellular lipid content, 357

intrauterine growth, 1880

iron, 1211

iron status, 1724

Italy, 765

J

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

job busyness, 458

job influence, 458

L

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

labor supply, 1637

lacto-ovo-vegetarian, 2007

large for gestational age, 2193

Latino, 980, 1616

lean body mass, 1571

lean mass, 480, 2284

left venticular mass, 368

left ventricle hypertophy, 1679

leptin, 9S, 36, 183, 192S, 215, 222S, 228S, 234S, 242S, 405, 423, 838, 1371, 1716, 1832, 1905, 2184, 2193

leptin action, 208S

leptin insufficiency, 1312

leptin receptor, 183, 778

life expectancy, 1264

lifestyle, 1654, 2107

lifestyle factors, 500

lifestyle modification, 737

light-molecular weight adiponectin, 1511

limbic system, 197S

linkage, 529, 1192

linolenic acid, 295

lipid metabolism, 1898

lipid peroxidation, 1921, 2224

lipids, 9S, 1046, 1868

lipodystrophy, 994

lipolysis, 398

liver fat, 336

local metabolism, 794

locomotion, 1789

longitudinal, 2266

longitudinal study, 753, 1010

Look AHEAD, 870

low-calorie diet, 115

low-carbohydrate diet, 1344

low-density muscle, 1164

lung, 1172

lying, 252

M

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

macronutrients, 1795

macrophage, 1353

macrovascular disease, 319

magnetic resonance imaging, 405, 1931

magnetic resonance spectroscopy, 34S, 228, 405

magnocellular, 259S

main component analysis, 1429

maternal-child interaction, 2026

maternal malnutrition, 1330

maternal morbidity, 770

MC4R, 1596

meal frequency, 215

meal patterns, 139

meal replacements, 1219

measurement, 2000

mechanical work, 1789

mediators, 97

melanocortin, 222S

membrane fluidity, 1505

men, 838, 1571

mendelian disorders, 529

menopause, 280

menstrual dysfunction, 1954

mental health, 1802, 2042

mesenteric adipose tissue, 1353

meta-analysis, 1283

metabolic diseases, 172

metabolic imprinting, 1371

metabolic rate, 673

metabolic risk, 2277

metabolic sensing, 192S

metabolic syndrome, 121S, 128S, 377, 500, 656, 759, 812, 1019, 1132, 1250, 1344, 1654, 2089, 2127, 2193

metabolism, 242S, 1294

metformin, 2107

α-Methyl-p-tyrosine, 1132

Mexican American, 1716, 1966

mice, 2145

microarray, 662, 974

milk, 1371

minority children, 1616

misclassification, 774, 2054

misreporting, 894

mitochondrial DNA depletion, 2193

mitogenactivated protein kinase, 1303

monocyte chemoattractant protein-1, 1353

Monte Carlo simulation, 1093

mood, 53S

morbidity, 165

mortality, 902, 2294

mothers, 518, 2026

mRNA, 1898

multifrequency, 2064

multiple regression analysis, 1181

muraglitazar, 143S

muscle, 826

myofibers, 1700

N

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

National Health and Nutrition Examination Survey, 2071

National Longitudinal Study of Adolescent Health, 701

National Weight Control Registry, 710, 1816

natural killer cell activity, 1211

neonatal morbidity, 770

neonate, 1535

neural plasticity, 345

neutrophins, 345

n-3 fatty acids, 295

night eating, 139

nitric oxide, 1505

nitric oxide synthase, 787

nocturnal eating, 77S

non-alcoholic fatty liver disease, 121S

non-invasive alternatives, 357

norepinephrine, 2018

nucleus accumbens, 197S

nucleus of the solitary tract, 216S

nurses, 458

nursing homes, 1472

nutrient intake, 1940

nutrition, 88, 717, 855

nutritional assessment, 258

O

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

obese transgenic mice, 1890

obesity/epidemiology, 701

obesity treatments, 1093

obesity trends, 1846

objective overeating, 77S

ob mRNA expression, 19

ob/ob mice, 199

observational study, 1429

obstetrics, 165, 770

obstructive, 1654

olanzapine, 36

older patients, 1402

omental fat, 199

on-line, 266

orlistat, 135S, 1716

osteoarthritis, 1274

ovariectomy, 1312

overfeeding, 690

overweight, 97, 289, 847, 855, 974, 980, 989, 1107, 1113, 1231, 1412, 1616, 1716, 1839, 1966, 2259, 2266

overweight/obese, 2277

oxidation, 1700

oxidative stress, 319, 2127

oxygen consumption, 673

P

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

palatable food, 197S

paraventricular nucleus, 259S

parental support, 1231

parent weight status, 2026

parvocellular, 259S

patient satisfaction, 1402

pediatric, 448, 774, 1647

peptide, 234S

peptide YY, 194, 683, 1523, 1553, 1562

peptide YY(3–36), 250S

perceived effectiveness, 464

perceived psychological stress, 1832

perceived social support, 122

percentage fat, 1685

percentage lean, 1685

percent body fat, 258, 480

perinatal, 165

perirenal fat, 199

phentermine, 135S

physical activity, 88, 280, 710, 980, 989, 1462, 1762, 1839, 2000, 2210

physical function, 1219

physical health, 2042

physical symptoms, 870

physician interaction, 1402

physician intervention, 1412

Pima Indians, 1515

pioglitazone, 143S

placenta, 1647

plastic surgery, 1626

polymorphism, 183, 188, 656

polyphenol, 1691

ponderal index at birth, 1257

pooled study, 717

portion size, 1795

position, 252

positive affect, 327

postmenopausal women, 1662, 2163

postprandial, 1747

Prader-Willi syndrome, 1028, 1685

predictive equation, 1181

predictors, 148

pregnancy, 63S, 1647

pregnancy complications, 165

pregnancy outcome, 165

preschool, 1949, 2026

preschool-aged children, 1107, 2034

prevalence, 373, 377, 765, 2089

prevention, 847, 1616

primary care, 373, 1412

prolactin, 1662

proopiomelanocortin, 228S, 254S

prophylaxis, 1961

prospective study, 458, 902

prospective study design, 106

prostatic hyperplasia, 172

psychological status, 2249

psychometrics, 2132

psychosocial status, 51S, 53S, 90S

puberty, 819

public health, 106, 1992

pulmonary diffusing capacity, 1172

Q

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

quality of life, 472, 1626

quantitative trait loci, 529

Quebec Family Study, 1605

questionnaire, 1832

R

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

race, 870, 1201, 1985

racial disparities, 1472

reactive oxygen species, 388

recombinant human leptin, 258

reducing, 1283

regional adiposity, 1975

regional differences, 28

regression-dilution bias, 2071

reliability, 63S

reporting bias, 1073

residence characteristics, 518

resistance exercise, 1921

resistant starch, 683, 1523

resistin, 60, 423, 1320

respiratory quotient, 215, 673

resting energy expenditure, 1755

restrictive, 1654

retinoids, 52

reverse causation, 2071

reverse transcriptase-polymerase chain reaction, 794

reward, 197S

RGS7 gene, 1605

rhythm, 1535

rimonabant, 143S

risk factors, 753, 1444

Roux-en-Y, 1553

Roux-en-Y gastric bypass, 383

running, 1975

S

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

safety, 518

salivary cortisol, 327

sarcopenia, 2277

satiation, 1363

satisfaction, 863

scale reliability and validity, 2132

schizophrenia, 2305

school, 88

schoolchildren, 1113

school marks, 1421

school performance, 1839

screening, 509

secretions, 234S

secular trend, 289, 1113

sedentary activity, 1596

self-help, 464, 1244

self-reported, 894

self-reported mental functional health, 884

self-reported physical functional health, 884

self-worth, 148

sensitivity, 696

serum amyloid A, 309

serum 1,25-OH2-D3, 1739

set-point, 192S

severe obesity, 383, 650, 696, 1886

sex, 235, 1985, 2080

sexual functioning, 472

sexual satisfaction, 472

short-chain fatty acids, 1523

Short Form-36 Health Survey, 1429

sibutramine, 135S, 1363

signal transducer and activator of transcription-5, 1303

Singapore, 1992

single-frequency, 2064

single frequency bioimpedance analysis, 252

single-nucleotide polymorphism, 1498

skeletal muscle, 357, 787, 1898

skinfolds, 2107

sleep, 1535

sleep-disordered breathing, 1985

small dense low-density lipoprotein, 812

smoking, 1257, 2294

smoking cessation, 1863

smoking during pregnancy, 2284

social support, 1762

socioeconomic position, 2080

socioeconomic status, 909, 1085

soda, 1825

soluble intercellular adhesion molecules, 2099

soluble transferrin receptor, 1724

soluble vascular cell adhesion molecules, 2099

South Asians, 759

Special Supplemental Nutrition Program for Women, Infants, and Children, 491

spirometry, 1654

squalene synthase, 1155

SR59230A, 1132

stair climbing, 2210

standing, 252

starvation, 216S

steps, 1392

stereotypes, 440

stess, 259S

stigma, 440, 1802

stigmatization, 1421

stress, 345

subcutaneous adipose tissue, 2163

subcutaneous fat, 1164

substrate metabolism, 1739

sugar-sweetened beverages, 1825

superoxide dismutase activity, 2184

suppressor of cytokine signaling-3, 254S, 1303

surveillance, 1107

survey, 2054

susceptibility to obesity, 106

Switzerland, 2080

sympathetic tone, 2018

symptoms, 1985

T

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

tailored advice, 847

television, 1816, 2034

temperature, 1535

temperature distribution, 1914

temperature sensitivity, 673

test–retest repeatability/reliability, 73

therapeutic lifestyle changes, 135S, 280

thermogenesis, 52

Third National Health and Nutrition Examination Survey, 480

threshold, 774

thromboembolism, 1961

time, 863

3T3-L1 adipocytes, 388, 1691

topiramate, 36

total activity, 1596

transgenic, 662

transgenic animals, 208S

Transmission Disequilibrium Test, 1605

treatment, 148, 1485

treatment preference, 2007

treatment-seeking, 122

trends, 717

triacylglycerol, 423

triglyceride, 1124

truncal fat mass, 1571

twins, 701

type 2 diabetes, 753, 1124, 1155, 1454, 1543, 2119, 2177

U

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

ubiquitin, 2136

ultrasound, 60

uncomplicated obesity, 368, 1679

uncoupling protein 2, 52, 656

underestimation, 2054

undergraduates, 1825

under-reporting, 156, 1073

United Kingdom SF-36, 884

university, 1421

University of North Carolina Alumni Heart Study, 1462

urban, 989

V

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

variability, 774

vascular permeability, 787

venule, 206

very-low-calorie diet, 1283

very severe obesity, 2177

videotape recording, 2132

visceral adipose tissue, 1019

visceral fat, 244, 319, 1046, 1064, 1164, 1931

visceral obesity, 1181, 1747

visfatin, 1886

visfatin/pre-B cell colony-enhancing factor, 2119

W

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

waist, 172

waist circumference, 336, 909, 1274, 1975, 2107

waist-to-hip ratio, 884, 1274

walking, 1771

weight, 289, 1010, 1637, 2236

Weight and Lifestyle Inventory, 51S, 53S, 63S, 70S, 83S, 90S

weight bias, 440

weight change, 458, 1383

weight gain, 14, 106, 491, 1438, 1444, 1825, 1863

weight gain/genetics, 701

weight gain prevention, 1392

weight history, 63S

weight loss, 28, 70S, 115, 148, 201S, 280, 309, 448, 710, 737, 1064, 1283, 1378, 1511, 1762, 1777, 2007

weight loss interventions, 1093

weight loss maintenance, 1816

weight loss programs, 645

weight maintenance, 710, 737, 1795

weight management, 1244, 1412, 1777, 1795

weight outcome, 431

weight reduction, 2184

weight-related distress, 2249

weight self-perception, 980

weight status, 1472, 2210

weigth loss, 1085

wellness, 88

white adipose tissue, 405, 1132

women, 1438, 1724, 1731, 2242

workforce participation, 920

Y

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

young children, 343

youth, 1579

Z

  1. Top of page
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. Y
  26. Z

zinc, 1211

Zucker rat model, 787, 1586